Commonly Used Diabetes Pill Increases the Risk of Heart Attacks and Possibly Death

A widely used diabetes pill raises the risk of heartGlaxoSmithKline in February 2007 noted that
attacks and possibly death, according to athere is a greater incidence of fractures of the
scientific analysis that reveals what some expertsupper arms, hands and feet in female diabetics
are calling another Vioxx-like example of thegiven rosiglitazone compared with those given
government failing to protect the public from anmetformin or glyburide.
unsafe drug. More than 6 million people worldwideThe diabetes drug Avandia can significantly
have taken the drug, sold as Avandia andincrease a patient's risk of heart attack according
Avandamet, since it came on the market eightto an analysis in today's Journal of the American
years ago to help control blood sugar in peopleMedical Association. Avandia, a widely used but
with the most common form of diabetes. Aboutcontroversial drug used to treat diabetes,
1 million Americans use Avandia on the daily basis.increased users' risk of heart attacks by 42
Avandia or Rosiglitazone is an anti-diabetic drug inpercent and doubled their risk of heart failure,
the thiazolidinedione class of drugs. It is marketedresearchers at Wake Forest University Baptist
by the pharmaceutical company GlaxoSmithKlineMedical Center have found. The study will appears
as a stand-alone drug Avandia and in combinationin the Journal of the American Medical Association.
with metformin (Avandamet) or with glimepirideFor the study, researchers looked at four clinical
(Avandaryl). Annual sales peaked at approx U.S.trials that enrolled more than 14,000 patients for
$4 Billion in 2008. A press release byat least a year.